Phase I Study to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection

NCT01905410 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: VVZ-149 Injection
DRUG: placebo

Sponsor

Vivozon, Inc.